Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 228
Filtrar
1.
J Infect Dis ; 186(6): 834-8, 2002 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-12198619

RESUMO

Thirty-two patients undergoing allogeneic hematopoietic stem-cell transplantation were given respiratory syncytial virus (RSV) immune globulin (RSVIG) at the time of transplantation and again 3 weeks later. Antibody titers to RSV, human parainfluenza virus 3, measles, and influenza H1N1, H3N2, and B were measured prior to administration of RSVIG and 6 more times over the course of the subsequent 6 weeks. Baseline antiviral titers and increases in antibody after administration of RSVIG were extremely variable for all the viruses. In 18 patients in whom the baseline titers of antibody titers to RSV-F protein were 1:640-1:2048, there was a 7.7-fold initial increase in these titers after the first dose of RSVIG, compared with a 2.1-fold increase in 14 patients with baseline titers of 1:4096-1:20,840; increases in titers of antibody against the other viruses after the first dose of RSVIG reflected similar variability. The subset of patients with the lowest titers appear to receive the greatest benefit from administration of RSVIG.


Assuntos
Anticorpos Antivirais/imunologia , Transplante de Células-Tronco Hematopoéticas , Imunização Passiva , Imunoglobulina G/imunologia , Infecções por Vírus Respiratório Sincicial/imunologia , Infecções por Vírus Respiratório Sincicial/prevenção & controle , Vírus Sinciciais Respiratórios/imunologia , Anticorpos Antivirais/administração & dosagem , Humanos , Imunoglobulina G/administração & dosagem , Imunoglobulinas Intravenosas/administração & dosagem , Imunoglobulinas Intravenosas/imunologia , Estudos Prospectivos
2.
Clin Infect Dis ; 34(1): 7-14, 2002 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-11731939

RESUMO

During the past several decades, there has been a steady increase in the frequency of opportunistic invasive fungal infections (IFIs) in immunocompromised patients. However, there is substantial controversy concerning optimal diagnostic criteria for these IFIs. Therefore, members of the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group formed a consensus committee to develop standard definitions for IFIs for clinical research. On the basis of a review of literature and an international consensus, a set of research-oriented definitions for the IFIs most often seen and studied in immunocompromised patients with cancer is proposed. Three levels of probability are proposed: "proven," "probable," and "possible." The definitions are intended for use in the context of clinical and/or epidemiological research, not for clinical decision making.


Assuntos
Aspergilose/complicações , Candidíase/complicações , Transplante de Células-Tronco Hematopoéticas , Hospedeiro Imunocomprometido/imunologia , Neoplasias/complicações , Infecções Oportunistas/complicações , Aspergilose/diagnóstico , Candidíase/diagnóstico , Tomada de Decisões , Humanos , Neoplasias/imunologia , Infecções Oportunistas/imunologia , Infecções Oportunistas/microbiologia
3.
J Infect Dis ; 184(9): 1093-7, 2001 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-11598830

RESUMO

Clinical manifestations and epidemiological features are described for a cluster of 12 cases of human parainfluenza virus 3 (HPIV3) infection that occurred among 64 allogeneic hematopoietic stem cell transplant (SCT) recipients in an 11-week period during spring 2000. Upper respiratory symptoms predominated. Pneumonia occurred in 3 patients and was a contributing factor in the death of 1 patient. Exposure histories and molecular analysis of HPIV3 isolates suggested that both community acquired and nosocomially transmitted infections occurred during this outbreak. A chain of transmission within the outpatient clinic appeared to have occurred in 4 outpatients and to have extended to 2 hospitalized patients. Molecular epidemiology was useful in discerning routes of transmission in this outbreak.


Assuntos
Surtos de Doenças , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Vírus da Parainfluenza 3 Humana/isolamento & purificação , Infecções por Respirovirus/epidemiologia , Proteína HN/genética , Humanos , Vírus da Parainfluenza 3 Humana/classificação , Vírus da Parainfluenza 3 Humana/genética , Infecções por Respirovirus/virologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Análise de Sequência de DNA , Transplante Homólogo
4.
J Orthop Sports Phys Ther ; 31(9): 504-10, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11570734

RESUMO

STUDY DESIGN: Predictive correlational study. OBJECTIVES: To identify the incidence of medial tibial stress syndrome (MTSS) in a group of high school cross-country runners and to determine if a relationship exists between lower extremity structural measures and the incidence of MTSS. BACKGROUND: Medial tibial stress syndrome is an overuse injury that occurs in long-distance runners. Literature exists that implicates structural deformity as a contributor to MTSS, but no studies have developed a predictive model. METHODS AND MEASURES: We measured 125 high school cross-country runners for tibiofibular varum, resting calcaneal position during stance, and gastrocnemius length. Runners developing MTSS over an 8-week period were placed in the injured group (2 men, 13 women; age 15.3 years 1.0), and 21 randomly selected uninjured runners were placed in the uninjured group (13 men, 8 women; age 15.7 years +/-1.5). Navicular drop was measured for runners in both groups. Reliability of measures was determined using an intraclass correlation coefficient (ICC 3,1). Paired t tests were used to compare the injury and noninjury groups. A logistic regression analysis was used to establish if the descriptive data could accurately predict the development of MTSS. RESULTS: Paired t tests showed a significant difference in navicular drop test measures between the injured (6.8 mm 3.7) and noninjured (3.6 mm 3.3) groups. Logistic regression analysis revealed navicular drop test measurements and sex correctly identified athletes who developed MTSS with 76% accuracy. CONCLUSION: Our study supported the hypothesis that a pronatory foot type is related to MTSS. The combination of sex and navicular drop test measures provides an accurate prediction for the development of MTSS. Clinical measures that identify biomechanical risk factors for MTSS may allow prevention or early intervention.


Assuntos
Doenças do Desenvolvimento Ósseo/epidemiologia , Transtornos Traumáticos Cumulativos/epidemiologia , Corrida/lesões , Tíbia/fisiopatologia , Adolescente , Doenças do Desenvolvimento Ósseo/fisiopatologia , Comorbidade , Transtornos Traumáticos Cumulativos/fisiopatologia , Feminino , Fíbula/fisiopatologia , Humanos , Incidência , Modelos Logísticos , Masculino , Músculo Esquelético/fisiopatologia , Postura/fisiologia , Valor Preditivo dos Testes , Fatores de Risco , Distribuição por Sexo , Estudantes , Ossos do Tarso/fisiopatologia , Estados Unidos/epidemiologia
5.
Clin Infect Dis ; 33(1): 95-106, 2001 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-11389501

RESUMO

Studies of invasive fungal infections have been and remain difficult to implement. Randomized clinical trials of fungal infections are especially slow and expensive to perform because it is difficult to identify eligible patients in a timely fashion, to prove the presence of the fungal infection in an unequivocal fashion, and to evaluate outcome in a convincing fashion. Because of these challenges, licensing decisions for antifungal agents have to date depended heavily on historical control comparisons and secondary advantages of the new agent. Although the availability of newer and potentially more effective agents makes these approaches less desirable, the fundamental difficulties of trials of invasive fungal infections have not changed. Therefore, there is a need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses, and this article summarizes the possible strategies in this area.


Assuntos
Antifúngicos/uso terapêutico , Ensaios Clínicos Controlados como Assunto/métodos , Micoses/tratamento farmacológico , Ensaios Clínicos Controlados Aleatórios como Assunto/métodos , Projetos de Pesquisa , Humanos , Resultado do Tratamento
7.
Bone Marrow Transplant ; 27(5): 537-42, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11313689

RESUMO

Viridans streptococci were the most common cause of bacteremia in 61 consecutive myeloablative allogeneic hematopoietic stem cell transplant (HSCT) recipients, occurring in 19 of 31 bacteremic patients (61%) during the period of post-transplant neutropenia. Seven of the 19 had more than one viridans streptococcus in the same blood culture. Twenty isolates from 15 patients were Streptococcus mitis. Most viridans streptococci were resistant to norfloxacin, used routinely for prophylaxis. Comparison of the 19 patients with viridans streptococcal bacteremia with a contemporaneous group of 23 allogeneic HSCT recipients with fever and neutropenia but no identified focus of infection found that patients with viridans streptococcal bacteremia were more likely to have severe intraoral pathology while neutropenic (26% vs 0%) and slightly shorter interval between the last dental procedure and the onset of neutropenia (11 vs 14 days). Poor underlying dental health and the use of norfloxacin thus appear to predispose to viridans streptococcal bacteremia.


Assuntos
Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Doenças Estomatognáticas/complicações , Infecções Estreptocócicas/etiologia , Adulto , Antibacterianos/administração & dosagem , Bacteriemia/tratamento farmacológico , Bacteriemia/etiologia , Feminino , Neoplasias Hematológicas/complicações , Neoplasias Hematológicas/terapia , Humanos , Masculino , Testes de Sensibilidade Microbiana , Infecções Estreptocócicas/tratamento farmacológico , Transplante Homólogo/efeitos adversos
8.
Clin Infect Dis ; 31(5): 1303-6, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11073772

RESUMO

Three previously normal patients with cryptococcal meningitis had intracranial lesions on computed tomography and magnetic resonance imaging that persisted for >5 years after successful cure with antifungal drugs. Persistence of lesions on neuroimaging should not be misinterpreted as evidence of active cryptococcosis.


Assuntos
Encefalopatias/patologia , Cryptococcus neoformans , Meningite Criptocócica/patologia , Adolescente , Adulto , Encéfalo/diagnóstico por imagem , Encéfalo/microbiologia , Encéfalo/patologia , Encefalopatias/diagnóstico por imagem , Encefalopatias/microbiologia , Humanos , Imageamento por Ressonância Magnética , Masculino , Meningite Criptocócica/diagnóstico por imagem , Meningite Criptocócica/microbiologia , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X
9.
Exp Brain Res ; 134(4): 483-9, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11081830

RESUMO

The ability of Huntington's disease patients to co-ordinate their two hands with and without external cueing was investigated. Twelve Huntington's disease patients and sex- and age-matched controls performed a bimanual cranking task at two speeds (0.5 Hz, 1.5 Hz) and phase relationships (in-phase, anti-phase), with and without an external metronome cue. Data were sampled at 200 Hz, and raw displacement data for each hand, mean and standard deviation measures of the relative positions of the two hands and their velocities were then calculated. All participants could perform the in-phase movement, at both speeds; however. the Huntington's disease patients were more variable and less accurate than the control participants, particularly at the fast speed. While controls could perform the anti-phase movement, in which rotation of the cranks differed by 180 degrees at both speeds, Huntington's disease patients were unable to do so at either speed, reverting to the in-phase movement at the slow speed. An external metronome cue did not improve the performance of the Huntington's disease patients, which differentiated this group from patients suffering from Parkinson's disease. The Huntington's disease patients' inability to perform the anti-phase movement may be due to damage to the basal ganglia and its output regions.


Assuntos
Mãos/inervação , Doença de Huntington/fisiopatologia , Músculo Esquelético/inervação , Desempenho Psicomotor , Adulto , Idoso , Feminino , Humanos , Doença de Huntington/genética , Masculino , Pessoa de Meia-Idade , Tempo de Reação , Valores de Referência
10.
Antimicrob Agents Chemother ; 44(11): 2985-90, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11036010

RESUMO

High-level azole resistance in the Darlington strain of Candida albicans was investigated by gene replacement in C. albicans and expression in Saccharomyces cerevisiae. We sequenced the ERG11 gene, which encodes the sterol C(14)alpha-demethylase, from our copy of the Darlington strain. Both alleles contained the histidine for tyrosine substitution at position 132 (Y132H) reported in Darlington by others, but we also found a threonine-for-isoleucine substitution (I471T) not previously reported in the C. albicans ERG11. The encoded I471T change in amino acids conferred azole resistance when overexpressed alone and increased azole resistance when added to the Y132H amino acid sequence in an S. cerevisiae expression system. Replacement of one copy of ERG11 in an azole-susceptible strain of C. albicans with a single copy of the Darlington ERG11 resulted in expression of the integrated copy and a modest increase in azole resistance. The profound azole resistance of the Darlington strain is the result of multiple mutations.


Assuntos
Antifúngicos/farmacologia , Candida albicans/genética , Cromossomos Fúngicos/genética , Sistema Enzimático do Citocromo P-450/genética , Fluconazol/farmacologia , Oxirredutases/genética , Substituição de Aminoácidos , Candida albicans/efeitos dos fármacos , Resistência Microbiana a Medicamentos/genética , Testes de Sensibilidade Microbiana , Mutagênese Sítio-Dirigida , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Saccharomyces cerevisiae/genética , Esterol 14-Desmetilase , Transfecção
11.
Clin Infect Dis ; 30(4): 696-709, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10770732

RESUMO

Aspergillosis comprises a variety of manifestations of infection. These guidelines are directed to 3 principal entities: invasive aspergillosis, involving several organ systems (particularly pulmonary disease); pulmonary aspergilloma; and allergic bronchopulmonary aspergillosis. The recommendations are distilled in this summary, but the reader is encouraged to review the more extensive discussions in subsequent sections, which show the strength of the recommendations and the quality of the evidence, and the original publications cited in detail. Invasive aspergillosis. Because it is highly lethal in the immunocompromised host, even in the face of therapy, work-up must be prompt and aggressive, and therapy may need to be initiated upon suspicion of the diagnosis, without definitive proof (BIII). Intravenous therapy should be used initially in rapidly progressing disease (BIII). The largest therapeutic experience is with amphotericin B deoxycholate, which should be given at maximum tolerated doses (e.g., 1-1.5 mg/kg/d) and should be continued, despite modest increases in serum creatinine levels (BIII). Lipid formulations of amphotericin are indicated for the patient who has impaired renal function or who develops nephrotoxicity while receiving deoxycholate amphotericin (AII). Oral itraconazole is an alternative for patients who can take oral medication, are likely to be adherent, can be demonstrated (by serum level monitoring) to absorb the drug, and lack the potential for interaction with other drugs (BII). Oral itraconazole is attractive for continuing therapy in the patient who responds to initial iv therapy (CIII). Therapy should be prolonged beyond resolution of disease and reversible underlying predispositions (BIII). Adjunctive therapy (particularly surgery and combination chemotherapy, also immunotherapy), may be useful in certain situations (CIII). Aspergilloma. The optimal treatment strategy for aspergilloma is unknown. Therapy is predominantly directed at preventing life-threatening hemoptysis. Surgical removal of aspergilloma is definitive treatment, but because of significant morbidity and mortality it should be reserved for high-risk patients such as those with episodes of life-threatening hemoptysis, and considered for patients with underlying sarcoidosis, immunocompromised patients, and those with increasing Aspergillus-specific IgG titers (CIII). Surgical candidates would need to have adequate pulmonary function to undergo the operation. Bronchial artery embolization rarely produces a permanent success, but may be useful as a temporizing procedure in patients with life-threatening hemoptysis. Endobronchial and intracavitary instillation of antifungals or oral itraconazole may be useful for this condition. Since the majority of aspergillomas do not cause life-threatening hemoptysis, the morbidity and cost of treatment must be weighed against the clinical benefit. Allergic bronchopulmonary aspergillosis (APBA). Although no well-designed studies have been carried out, the available data support the use of corticosteroids for acute exacerbations of ABPA (AII). Neither the optimal corticosteroid dose nor the duration of therapy has been standardized, but limited data suggest the starting dose should be approximately 0.5 mg/kg/d of prednisone. The decision to taper corticosteroids should be made on an individual basis, depending on the clinical course (BIII). The available data suggest that clinical symptoms alone are inadequate to make such decisions, since significant lung damage may occur in asymptomatic patients. Increasing serum IgE levels, new or worsening infiltrate on chest radiograph, and worsening spirometry suggest that corticosteroids should be used (BII). Multiple asthmatic exacerbations in a patient with ABPA suggest that chronic corticosteroid therapy should be used (BIII). Itraconazole appears useful as a corticosteroid sparing agent (BII). (ABSTRACT TRUNCATED)


Assuntos
Antifúngicos/uso terapêutico , Aspergilose/tratamento farmacológico , Aspergilose/diagnóstico , Aspergillus/efeitos dos fármacos , Humanos , Pneumopatias Fúngicas/tratamento farmacológico , Pneumopatias Fúngicas/microbiologia
12.
Arch Pediatr Adolesc Med ; 154(1): 43-8, 2000 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10632249

RESUMO

OBJECTIVE: To describe parents' values for outcomes of occult bacteremia using utility assessment, a quantitative method that incorporates risk preference. DESIGN: Computer-based utility assessment interview. SETTING: Urban children's hospital pediatric emergency department with 50 000 visits annually. PARTICIPANTS: Convenience sample of parents presenting with a child between 3 and 36 months. MAIN OUTCOME MEASURE: Parents' utility values for 8 outcomes from treatment of occult bacteremia: blood drawing, localized infection, hospitalization for antibiotics, meningitis with recovery, meningitis resulting in deafness, minor brain damage, severe brain damage, and death. RESULTS: Ninety-four subjects successfully completed the interview. Mean utilities were 0.9974 for blood drawing, 0.9941 for local infection, 0.9921 for hospitalization, 0.9768 for meningitis with recovery, 0.8611 for deafness, 0.7393 for minor brain damage, 0.3903 for severe brain damage, and 0.0177 for death. All values were significantly different from those that immediately preceded and succeeded (P<.0001), except for local infection vs hospitalization (P = .14). Median utilities for blood drawn, local infection, and hospitalization were 1. There were no significant differences among utilities of parents who presented with a febrile child (temperature > or =39 degrees C), or an afebrile child (temperature <39 degrees C). There were also no significant differences among utilities regardless of whether parents had children with prior experience with the outcomes. CONCLUSIONS: Assessment of utilities for outcomes of occult bacteremia yielded extremely high mean and median values for outcomes without permanent sequelae. This suggests that parents presenting to an emergency department may rationally prefer painful transient experiences, including venipuncture, for their children rather than risk even rare chances of severe outcomes.


Assuntos
Bacteriemia/epidemiologia , Pais/psicologia , Adulto , Bacteriemia/diagnóstico , Bacteriemia/tratamento farmacológico , Feminino , Febre de Causa Desconhecida/etiologia , Humanos , Masculino , Satisfação do Paciente , Medição de Risco , Assunção de Riscos , Resultado do Tratamento
13.
Med Mycol ; 38 Suppl 1: 199-204, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11204146

RESUMO

A symposium was held on May 8, 2000 to discuss the management of deep infections with Candida species. Among the findings discussed were the following. Candiduria is most often benign, though it occurs in patients with serious underlying diseases. Candida species are now the fourth most common cause of nosocomial bloodstream infections, usually arising from an intravenous catheter. Candida albicans represents only 50-60% of the isolates. There has been no change in the frequency of fluconazole resistance in C. albicans but some of the other species now being isolated from blood are constitutively more resistant to this drug. Nevertheless, for most non-neutropenic patients with candidemia, fluconazole is a reasonable choice for initial therapy. In the neutropenic patient, candidemia is now uncommon. Deep candida infections in neutropenic patients are usually being treated empirically with an amphotericin B formulation. Hepatosplenic candidiasis is usually detected only after recovery from neutropenia but can be suspected by imaging techniques. Improved diagnostic techniques for deep candidiasis in the neutropenic patient remain a critical requirement.


Assuntos
Candida , Candidíase , Fungemia , Neutropenia/complicações , Antifúngicos/uso terapêutico , Candida/crescimento & desenvolvimento , Candida/isolamento & purificação , Candida/patogenicidade , Candidíase/diagnóstico , Candidíase/tratamento farmacológico , Candidíase/epidemiologia , Candidíase/microbiologia , Fungemia/diagnóstico , Fungemia/tratamento farmacológico , Fungemia/epidemiologia , Fungemia/microbiologia , Humanos , Agências Internacionais , Infecções Urinárias/diagnóstico , Infecções Urinárias/microbiologia
14.
Gene ; 236(1): 43-51, 1999 Aug 05.
Artigo em Inglês | MEDLINE | ID: mdl-10433965

RESUMO

The C-5 sterol desaturase gene (ERG3), essential for yeast ergosterol biosynthesis, was cloned and sequenced from Candida albicans by homology with the Saccharomyces cerevisiae ERG3. The ERG3 ORF contained 1158bp and encoded 386 deduced amino acids. The clone was used to transform a gal1 mutant derived from the Darlington strain of C. albicans, using galactose selection. The Darlington strain is known to lack Delta(5,6) sterols, i.e. to have an erg3 phenotype (Howell, S.A., et al., 1990. J. Appl. Bacteriol. 69, 692-696). The transformant (CDTR1) contained six tandem integrated ERG3GAL1 repeats, had double the abundance of ERG3 transcript found in the host strain, and synthesized ergosterol, a Delta(5,6) sterol.The Darlington strain was noted to have an abundance of ERG3 transcript. Both ERG3 alleles in Darlington were cloned and sequenced in order to look for changes that might explain the erg3 phenotype. One allele, called Dar-2, contained a stop codon in place of tryptophan-292. The other ERG3 allele, called Dar-1, had changes in three amino acids, two of which were conserved in three fungal and one plant species. EcoRI genomic fragments containing ERG3 from the Dar-1 allele and from B311, the wild-type strain, were inserted into the plasmid pRS316 and used to transform a Saccharomyces cerevisiae erg3,ura3 mutant using uracil selection. The 4.1kb ERG3 fragments from the B311 and Dar-1 both contained 1. 4kb 5' and 1.5kb 3' flanking sequences around the coding region. Transformants with ERG3 from B311 but not from Dar-1 showed restored ergosterol synthesis. One or more of these three deduced amino acids in the Dar-1 allele of ERG3 appeared critical for function.


Assuntos
Candida albicans/genética , Oxirredutases/genética , Sequência de Aminoácidos , Azóis/farmacologia , Southern Blotting , Candida albicans/efeitos dos fármacos , Candida albicans/enzimologia , Clonagem Molecular , Regulação Fúngica da Expressão Gênica , Genótipo , Modelos Genéticos , Dados de Sequência Molecular , Fenótipo , Homologia de Sequência de Aminoácidos , Esteróis/metabolismo , Transcrição Gênica , Transformação Genética
15.
Antimicrob Agents Chemother ; 43(7): 1725-8, 1999 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10390230

RESUMO

Sterol delta22-desaturase has been purified from a strain of Candida glabrata with a disruption in the gene encoding sterol 14alpha-demethylase (cytochrome P-45051; CYP51). The purified cytochrome P-450 exhibited sterol delta22-desaturase activity in a reconstituted system with NADPH-cytochrome P-450 reductase in dilaurylphosphatidylcholine, with the enzyme kinetic studies revealing a Km for ergosta-5,7-dienol of 12.5 microM and a Vmax of 0. 59 nmol of this substrate metabolized/min/nmol of P-450. This enzyme is encoded by CYP61 (ERG5) in Saccharomyces cerevisiae, and homologues have been shown in the Candida albicans and Schizosaccharomyces pombe genome projects. Ketoconazole, itraconazole, and fluconazole formed low-spin complexes with the ferric cytochrome and exhibited type II spectra, which are indicative of an interaction between the azole moiety and the cytochrome heme. The azole antifungal compounds inhibited reconstituted sterol delta22-desaturase activity by binding to the cytochrome with a one-to-one stoichiometry, with total inhibition of enzyme activity occurring when equimolar amounts of azole and cytochrome P-450 were added. These results reveal the potential for sterol delta22-desaturase to be an antifungal target and to contribute to the binding of drugs within the fungal cell.


Assuntos
Candida/enzimologia , Sistema Enzimático do Citocromo P-450/isolamento & purificação , Oxirredutases/isolamento & purificação , Antifúngicos/farmacologia , Inibidores das Enzimas do Citocromo P-450 , Oxirredutases/antagonistas & inibidores , Proteínas de Saccharomyces cerevisiae
16.
Clin Infect Dis ; 28(3): 629-33, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10194090

RESUMO

Hydrocephalus can be associated with increased morbidity and mortality in cryptococcal meningitis if left untreated. Both ventriculoperitoneal and ventriculoatrial shunting have been used in persons with cryptococcosis complicated by hydrocephalus, but the indications for and complications, success, and timing of these interventions are not well known. To this end, we reviewed the clinical courses of 10 non-human immunodeficiency virus-infected patients with hydrocephalus secondary to cryptococcal meningitis who underwent shunting procedures. Nine of 10 patients who underwent shunting had noticeable improvement in dementia and gait. Two patients required late revision of their shunts. Shunt placement in eight patients with acute infection did not disseminate cryptococcal infection into the peritoneum or bloodstream, nor did shunting provide a nidus from which Cryptococcus organisms proved difficult to eradicate. Shunting procedures are a safe and effective therapy for hydrocephalus in patients with cryptococcal meningitis and need not be delayed until patients are mycologically cured.


Assuntos
Derivações do Líquido Cefalorraquidiano , Hidrocefalia/cirurgia , Meningite Criptocócica/complicações , Derivação Ventriculoperitoneal , Adolescente , Adulto , Anfotericina B/uso terapêutico , Antifúngicos/uso terapêutico , Feminino , Flucitosina/uso terapêutico , Humanos , Hidrocefalia/diagnóstico por imagem , Hidrocefalia/etiologia , Masculino , Meningite Criptocócica/tratamento farmacológico , Pessoa de Meia-Idade , Radiografia , Resultado do Tratamento
17.
Med Mycol ; 36(3): 165-8, 1998 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9776829

RESUMO

Air sampling of the rooms and corridors of the oncology wards of the hospital was carried out over a 54-week period to assess the concentration of viable Aspergillus conidia. A. fumigatus and A. flavus were recovered at a mean of 1.83 cfu m-3 air sampled. Individual samplings yielded concentrations of up to 11.6 cfu m-3. Other Aspergillus spp. were recovered at a mean of 2.38 cfu m-3 (maximum 32.6 cfu m-3). Concentration was not correlated with season or hospital ward. Review of autopsy results showed an average of 6.6 cases of aspergillosis annually over a 22-year period. No seasonal variation in case incidence was found. Six cases of invasive aspergillosis were diagnosed on the three cancer wards during the air-sampling period, but no association was seen linking these cases with changes in recovery of airborne Aspergillus. A seasonal pattern was not observed in the overall incidence of aspergillosis cases nor concentrations of airborne conidia.


Assuntos
Microbiologia do Ar , Aspergilose/epidemiologia , Aspergillus flavus/isolamento & purificação , Aspergillus fumigatus/isolamento & purificação , Poluição do Ar em Ambientes Fechados , Autopsia , Humanos , Incidência , National Institutes of Health (U.S.) , Quartos de Pacientes , Estudos Retrospectivos , Estados Unidos
18.
Clin Infect Dis ; 27(2): 260-4, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9709874

RESUMO

Flucytosine (5-FC) monotherapy for cryptococcosis is not advocated because drug resistance emerges during therapy. Reported documentation of this widely accepted belief is surprisingly scarce. Therefore, we reviewed our experience with 5-FC monotherapy for 27 patients treated between 1968 and 1973. Patients were selected on the basis of criteria associated with good prognosis. In this group, 5-FC monotherapy resulted in cure in eight cases and improvement in two. Overall, response was seen in 10 (43%) of 23 evaluable patients. Therapy failed for 13 patients, including 5 who relapsed, 2 who had partial responses, and 6 without response. Resistance was noted to have developed in isolates from six (50%) of 12 patients for whom therapy failed. Although the 57% failure rate associated with 5-FC alone precludes its use as monotherapy, our study did show that this treatment was well tolerated and that failure was not invariably associated with development of resistance.


Assuntos
Antifúngicos/uso terapêutico , Criptococose/tratamento farmacológico , Flucitosina/uso terapêutico , Adulto , Idoso , Cryptococcus neoformans/efeitos dos fármacos , Resistência Microbiana a Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
19.
Antimicrob Agents Chemother ; 42(7): 1695-701, 1998 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9661006

RESUMO

Sequential Candida glabrata isolates were obtained from the mouth of a patient infected with human immunodeficiency virus type 1 who was receiving high doses of fluconazole for oropharyngeal thrush. Fluconazole-susceptible colonies were replaced by resistant colonies that exhibited both increased fluconazole efflux and increased transcripts of a gene which codes for a protein with 72.5% identity to Pdr5p, an ABC multidrug transporter in Saccharomyces cerevisiae. The deduced protein had a molecular mass of 175 kDa and was composed of two homologous halves, each with six putative transmembrane domains and highly conserved sequences of ATP-binding domains. When the earliest and most azole-susceptible isolate of C. glabrata from this patient was exposed to fluconazole, increased transcripts of the PDR5 homolog appeared, linking azole exposure to regulation of this gene.


Assuntos
Antifúngicos/farmacologia , Candida/genética , Fluconazol/farmacologia , Proteínas Fúngicas , Proteínas de Membrana/genética , Proteínas de Saccharomyces cerevisiae , Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Infecções Oportunistas Relacionadas com a AIDS/microbiologia , Sequência de Aminoácidos , Transporte Biológico , Northern Blotting , Southern Blotting , Candida/efeitos dos fármacos , Candidíase/complicações , Candidíase/microbiologia , Resistência Microbiana a Medicamentos/genética , Humanos , Masculino , Proteínas de Membrana/fisiologia , Pessoa de Meia-Idade , Dados de Sequência Molecular , Homologia de Sequência de Aminoácidos
20.
Med Mycol ; 36 Suppl 1: 258-65, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9988515

RESUMO

Over 500,000 workers in the USA alone are employed in laboratories that range from small physician offices to large clinical laboratories handling microbes for comprehensive research and/or diagnostic work. These workers are exposed to a variety of potential occupational health risks such as exposure to infectious clinical materials, environmental specimens, cultures, complex and inflammable chemicals, radiation, and electrical and mechanical hazards. As members of the International Society for Human and Animal Mycology, we have no policy statement on biosafety standards for handling medically important fungi. The intent of the symposium is to cover some of the important aspects of biosafety; (1) standards in handling dimorphic fungal pathogens; (2) the principles and criteria of biosafety levels and classification of known medically important fungi, aerobic actinomycetes, environmental fungi according to their biosafety levels; (3) medically important fungal waste and its safe disposal; and (4) biosafety and regulatory considerations in handling and mailing medically important fungi in a culture collection.


Assuntos
Contenção de Riscos Biológicos , Fungos/patogenicidade , Laboratórios/normas , Infecção Laboratorial/prevenção & controle , Micoses/prevenção & controle , Animais , Humanos , Infecção Laboratorial/transmissão , Eliminação de Resíduos de Serviços de Saúde , Micologia , Micoses/transmissão
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...